Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization

Nanoparticles (NPs) were widely used in drugs/probes delivery for improved disease diagnosis and/or treatment. Targeted delivery to cancer cells is a highly attractive application of NPs. However, few studies have been performed on the targeting mechanisms of these ligand-modified delivery systems. Additional studies are needed to understand the transport of nanoparticles in the cancer site, the interactions between nanoparticles and cancer cells, the intracellular trafficking of nanoparticles within the cancer cells and the subcellular destiny and potential toxicity. Interleukin 13 (IL-13) peptide can specifically bind IL-13Rα2, a receptor that is highly expressed on glioma cells but is expressed at low levels on other normal cells. It was shown that the nanoparticels modification with the IL-13 peptide could improve glioma treatment by selectively increasing cellular uptake, facilitating cell internalization, altering the uptake pathway and increasing glioma localization.

[1]  P. Fatouros,et al.  Encapsulation of a radiolabeled cluster inside a fullerene cage, (177)Lu(x)Lu((3-x))N@C(80): an interleukin-13-conjugated radiolabeled metallofullerene platform. , 2010, Journal of the American Chemical Society.

[2]  Sagar Agarwal,et al.  Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain , 2011, Expert Reviews in Molecular Medicine.

[3]  Xin-guo Jiang,et al.  Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. , 2011, Biomaterials.

[4]  W. Lu,et al.  Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. , 2006, Cancer research.

[5]  I. Madshus,et al.  Preubiquitinated chimeric ErbB2 is constitutively endocytosed and subsequently degraded in lysosomes. , 2013, Experimental cell research.

[6]  Morteza Mahmoudi,et al.  Effect of nanoparticles on the cell life cycle. , 2011, Chemical reviews.

[7]  Leonhard Möckl,et al.  Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand. , 2012, Nano letters.

[8]  B. Ruggeri,et al.  The effects of the oral, pan-VEGF-R kinase inhibitor CEP-7055 and chemotherapy in orthotopic models of glioblastoma and colon carcinoma in mice , 2006, Molecular Cancer Therapeutics.

[9]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[10]  Rongrong Hua,et al.  Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats. , 2010, Molecular pharmaceutics.

[11]  N. Christensen,et al.  IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13. , 2002, Neoplasia.

[12]  Yu Liu,et al.  Recent advances in brain tumor-targeted nano-drug delivery systems , 2012, Expert opinion on drug delivery.

[13]  K. Thorn,et al.  Regulation of Endocytic Clathrin Dynamics by Cargo Ubiquitination , 2012, Developmental cell.

[14]  Cao Xie,et al.  Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Xiaoling Fang,et al.  Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. , 2011, Biomaterials.

[16]  W. Marshall,et al.  Analysis of Clathrin-mediated Endocytosis of Epidermal Growth Factor Receptor by RNA Interference*[boxs] , 2004, Journal of Biological Chemistry.

[17]  Esther H Chang,et al.  Does a targeting ligand influence nanoparticle tumor localization or uptake? , 2008, Trends in biotechnology.

[18]  J. Shapiro,et al.  Endocytosis and Signal Transduction: Basic Science Update , 2003, Biological research for nursing.

[19]  Mark E. Davis,et al.  Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.

[20]  Quanyin Hu,et al.  PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy. , 2013, Biomaterials.

[21]  Brian Storrie,et al.  Capacity of the Golgi apparatus for cargo transport prior to complete assembly. , 2006, Molecular biology of the cell.

[22]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Hyesung Jeon,et al.  Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Wei Lu,et al.  Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Mark B. Carter,et al.  The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers , 2011, Nature materials.

[26]  Yuan Yu,et al.  Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes. , 2011, International journal of pharmaceutics.

[27]  Xiaoling Fang,et al.  Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. , 2012, Biomaterials.

[28]  Steven A Curley,et al.  Internalization of C60 fullerenes into cancer cells with accumulation in the nucleus via the nuclear pore complex. , 2012, Biomaterials.

[29]  Xinguo Jiang,et al.  The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. , 2012, Biomaterials.

[30]  Rongqin Huang,et al.  Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. , 2013, Journal of the American Chemical Society.

[31]  R. Puri,et al.  Mutation and functional analysis of IL-13 receptors in human malignant glioma cells. , 2001, Oncology research.

[32]  Xin-guo Jiang,et al.  Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. , 2012, Biomaterials.

[33]  Lu Wang,et al.  Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. , 2012, ACS nano.

[34]  U. Nielsen,et al.  Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.

[35]  Alexander T Florence,et al.  "Targeting" nanoparticles: the constraints of physical laws and physical barriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Omid C Farokhzad,et al.  Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. , 2011, Accounts of chemical research.

[37]  G. Kibria,et al.  Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[38]  L. E. Johannessen,et al.  A Chimeric Pre‐ubiquitinated EGF Receptor is Constitutively Endocytosed in a Clathrin‐Dependent, but Kinase‐Independent Manner , 2011, Traffic.

[39]  Xinguo Jiang,et al.  Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome. , 2011, Biomaterials.

[40]  P. Fatouros,et al.  Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors. , 2011, Nanomedicine.

[41]  B. Zhang,et al.  PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery. , 2013, Biomaterials.